AU Patent

AU2006220100B2 — Pharmaceutical forms with improved pharmacokinetic properties

Assigned to Bayer Intellectual Property GmbH · Expires 2011-08-18 · 15y expired

What this patent protects

The invention relates to novel pharmaceutical formulations of Vardenafil, which rapidly dissolve in the mouth and lead to an increase in bioavailability and a plateau-shaped plasma concentration curve and method for production thereof.

USPTO Abstract

The invention relates to novel pharmaceutical formulations of Vardenafil, which rapidly dissolve in the mouth and lead to an increase in bioavailability and a plateau-shaped plasma concentration curve and method for production thereof.

Drugs covered by this patent

vardenafil-hydrochloride (VARDENAFIL HYDROCHLORIDE)

Patent Metadata

Patent number: AU2006220100B2
Jurisdiction: AU
Classification: —
Expires: 2011-08-18
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Intellectual Property GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.